Clinical Trial Update: REP1 Gene Replacement Therapy for Choroideremia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for REP1 gene replacement therapy in choroideremia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroideremia

Drugs mentioned

• REP1 gene replacement therapy (REP1 gene replacement therapy)

Snippet

Sponsor: University of Oxford | Conditions: Choroideremia | Phase 2 | Status: COMPLETED